entertainment -WSS

entertainment

author：entertainment 2025-09-06 02:13:12 - browse：7

health system simulate simulation — Adobe

Venture firms, convinced they’re jumpstarting the world’s most helpful tech products, have struggled mightily to get them in the hands of cash-strapped, risk-averse hospital administrators and clinicians — but that could change as tech startups and their powerful backers explore ever closer relationships with health care providers.

Among them is General Catalyst, which on Sunday announced a health business spinout with plans to buy a health system of its very own. The new business, called the Health Assurance Transformation Corporation or HATCo, is on the lookout for health systems to purchase. The idea is to create a testing ground for new tech that could improve patients’ health while making hospital processes more efficient. General Catalyst — which has backed household names like Airbnb and Warby Parker well before they were successful companies — did not say how much they’d invest to acquire a health system.

It’s the most overt attempt by a venture firm to directly shape how hospitals use technology to provide care. General Catalyst already works closely with a network of 15 health systems across 43 states eager for early access to technology developed by its portfolio companies and companies it has launched — including IT software developers like Commure — but has so far operated as more of a partner to health systems than an owner.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

explore

WSS

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Hospitals are piloting generative AI tools as regulators play catch

New study raises questions about niacin and heart health

Opioid cravings were reduced by anti

Burning questions for the 2024 JPM Healthcare Conference

knowledge

entertainment

hotspot

Apple is now the first public company to be valued at $3 trillion

Opioid cravings were reduced by anti

Drug repurposing or repositioning? The language matters

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

As demand for Covid shots wanes, Moderna seeks its next success

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Chronically ill young patients struggle to find fertility info

United colonoscopy coverage change 'may cost lives,' doctors say

3 medical device trends to watch in 2024

explore

Videos point to link between seizures and unexplained toddler deaths

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

How a scoliosis diagnosis changed the life of one young dancer

As AI regulations shape up, health tech startups beg for clarity

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

hotspot

explore

leisure time

explore